45 results on '"DEL PRATO, Stefano"'
Search Results
2. 97-OR: Fatty Liver Index (FLI) Is an Independent Risk Factor for All-Cause Mortality and Cardiovascular Events in Type 1 Diabetes (T1D) : A 10-Year Observational Study
3. 258-OR: Sustainability of HbA1c Control of Tirzepatide vs. Insulin Glargine in People with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
4. 749-P: Clinically Relevant Predictors of Cardiovascular Events: Exploratory Analysis from the VERIFY Study of Initial Treatment of Type 2 Diabetes Mellitus
5. 54-LB: Distinct Mechanisms Are Responsible for the Increase in Endogenous Glucose Production and Ketone Formation following Empagliflozin in T2DM Patients
6. 90-LB: Characterization of Tirzepatide-Treated patients achieving HbA1c <5.7% in the SURPASS 1-4 Trials
7. 986-P: Evaluation of Cardiovascular Risk and All-Cause Mortality in Type 1 Diabetes: Comparison of Risk Engines in a 10-Year Follow-up
8. Endothelial Nitric Oxide Synthase (eNOS) Glu298Asp and T-786C Gene Polymorphisms and Metabolic Syndrome in Essential Hypertensive Men: 2356-PO
9. Islets in Human Type 2 Diabetes Show Evidence for Arrested Regeneration: 335-OR
10. Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes
11. A Common Polymorphism in the Promoter of UCP2 Contributes to the Variation in Insulin Secretion in Glucose-Tolerant Subjects
12. Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets: Evidence that β-Cell Death Is Caspase Mediated, Partially Dependent on Ceramide Pathway, and Bcl-2 Regulated
13. Insulin Secretory Function Is Impaired in Isolated Human Islets Carrying the Gly972→Arg IRS-1 Polymorphism
14. Lipotoxicity in Human Pancreatic Islets and the Protective Effect of Metformin
15. Phasic Insulin Release and Metabolic Regulation in Type 2 Diabetes
16. Insulin secretory function is impaired in isolated human islets carrying the [Gly.sup.972] → Arg IRS-1 polymorphism. (Brief Genetics Report)
17. Effects of Glucosamine Infusion on Insulin Secretion and Insulin Action in Humans
18. Protein Kinase C Activity Is Acutely Regulated by Plasma Glucose Concentration in Human Monocytes In Vivo
19. Effect of Acute Ketosis on the Endothelial Function of Type 1 Diabetic Patients: The Role of Nitric Oxide
20. Restoration of Early Rise in Plasma Insulin Levels Improves the Glucose Tolerance of Type 2 Diabetic Patients
21. Enhanced Responsiveness of Blood Pressure to Sodium Intake and to Angiotensin II Is Associated With Insulin Resistance in IDDM Patients With Microalbuminuria
22. Forearm Nitric Oxide Balance, Vascular Relaxation, and Glucose Metabolism in NIDDM Patients
23. Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM
24. Bedtime Insulin/daytime Glipizide: Effective Therapy for Sulfonylurea Failures in NIDDM
25. Bedtime insulin daytime glipizide: effective therapy for sulfonylurea failures in NIDDM
26. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension
27. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women
28. Ketone body metabolism in NIDDM: effect of sulfonylurea treatment
29. Independent Association of a Metabolic Syndrome Severity Score with All-Cause Mortality in Type 1 Diabetes—A 10-Year Follow-Up
30. Cognitive Function and Brain Plasticity in Obese Patients—The Impact of Bariatric Surgery
31. Metabolic Features of Impaired Glucose Regulation in Caucasians
32. Glomerular Hypertension and Insulin Resistance are Determinants of Microalbuminuria in Type 1 Diabetic Patients
33. Elevated Plasma Free Fatty Acids Alter Endothelial-dependent Vasodilation Irrespectively of Chain Length and Prostaglandin Production
34. The Metabolic Syndrome in the European Population: The Experience of the European Group on Insulin Resistance (EGIR)
35. Early Insulin Secretion is a Determinant of Glucose Tolerance in Diabetic and Non-Diabetic Subjects
36. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.
37. Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism.
38. Insulin Sensitivity, Binding, and Kinetics in Pancreatogenic and Type I Diabetes.
39. 175-OR: Effect of Alirocumab in Individuals with Type 2 Diabetes and High Triglycerides and Low High-Density Lipoprotein Cholesterol.
40. Pre-Existing Diabetes (PED) in Liver Transplant Patients (LTP).
41. Effects of Therapeutical Concentration of Immunosuppressant Drugs on Isolated Human Pancreatic Islets: Functional and Molecular Studies.
42. G-Protein-Coupled Receptor 40 (gpr40) Expression in Human Pancreatic Islets: Regulation by Glucose, Fatty Acids and Type 2 Diabetes.
43. Pancreatic Beta Cell Altered Autophagy in Human Type 2 Diabetes (T2DM).
44. Soluble CD40 Ligand and C-Reactive Protein Concentrations Are Affected by Glucose and Insulin Levels in Subjects with Essential Hypertension.
45. Circulating Endothelial Progenitor Cells (EPCs) in Subjects with Impaired Glucose Regulation (Pre-Diabetes).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.